Literature DB >> 22723509

Review and uses of stereotactic body radiation therapy for oligometastases.

Filippo Alongi1, Stefano Arcangeli, Andrea Riccardo Filippi, Umberto Ricardi, Marta Scorsetti.   

Abstract

In patients with proven distant metastases from solid tumors, it has been a notion that the condition is incurable, warranting palliative care only. The term "oligometastases" was coined to refer to isolated sites of metastasis, whereby the entire burden of disease can be recognized as a finite number of discrete lesions that can be potentially cured with local therapies. Stereotactic body radiation therapy (SBRT) is a novel treatment modality in radiation oncology that delivers a very high dose of radiation to the tumor target with high precision using single or a small number of fractions. SBRT is the result of technological advances in patient and tumor immobilization, image guidance, and treatment planning and delivery. A number of studies, both retrospective and prospective, showed promising results in terms of local tumor control and, in a limited subset of patients, of survival. This article reviews the radiobiologic, technical, and clinical aspects of SBRT for various anatomical sites.

Entities:  

Mesh:

Year:  2012        PMID: 22723509      PMCID: PMC3425528          DOI: 10.1634/theoncologist.2012-0092

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  74 in total

Review 1.  Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.

Authors:  Yasushi Nagata; Joern Wulf; Ingmar Lax; Robert Timmerman; Frank Zimmermann; Igor Stojkovski; Branislav Jeremic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-01       Impact factor: 7.038

Review 2.  Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.

Authors:  Shankar Siva; Michael MacManus; David Ball
Journal:  J Thorac Oncol       Date:  2010-07       Impact factor: 15.609

Review 3.  [Trends in radiation therapy for the treatment of metastatic and oligometastatic disease in 2010].

Authors:  J Thariat; P Y Marcy; J L Lagrange
Journal:  Bull Cancer       Date:  2010-12       Impact factor: 1.276

4.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.

Authors:  Karyn A Goodman; Ellen A Wiegner; Katherine E Maturen; Zhigang Zhang; Qianxing Mo; George Yang; Iris C Gibbs; George A Fisher; Albert C Koong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-28       Impact factor: 7.038

Review 5.  Stereotactic body radiation therapy: a novel treatment modality.

Authors:  Simon S Lo; Achilles J Fakiris; Eric L Chang; Nina A Mayr; Jian Z Wang; Lech Papiez; Bin S Teh; Ronald C McGarry; Higinia R Cardenes; Robert D Timmerman
Journal:  Nat Rev Clin Oncol       Date:  2009-12-08       Impact factor: 66.675

Review 6.  Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy.

Authors:  Jordan Torok; Rodney E Wegner; Steven A Burton; Dwight E Heron
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

Review 7.  Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis.

Authors:  Francesca Fiorentino; Ian Hunt; Kristine Teoh; Tom Treasure; Martin Utley
Journal:  J R Soc Med       Date:  2010-02       Impact factor: 5.344

Review 8.  American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.

Authors:  Sandra L Wong; Pamela B Mangu; Michael A Choti; Todd S Crocenzi; Gerald D Dodd; Gary S Dorfman; Cathy Eng; Yuman Fong; Andrew F Giusti; David Lu; Thomas A Marsland; Rob Michelson; Graeme J Poston; Deborah Schrag; Jerome Seidenfeld; Al B Benson
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

9.  Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.

Authors:  Quynh-Nhu Nguyen; Almon S Shiu; Laurence D Rhines; He Wang; Pamela K Allen; Xin Shelley Wang; Eric L Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-23       Impact factor: 7.038

10.  Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial.

Authors:  Damian E Dupuy; Dawei Liu; Donna Hartfeil; Lucy Hanna; Jeffrey D Blume; Kamran Ahrar; Robert Lopez; Howard Safran; Thomas DiPetrillo
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

View more
  61 in total

Review 1.  Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions.

Authors:  Timothy A Lin; Jessica S Lin; Timothy Wagner; Ngoc Pham
Journal:  J Gastrointest Oncol       Date:  2018-10

Review 2.  Stereotactic body radiation therapy for liver metastases.

Authors:  Marta Scorsetti; Elena Clerici; Tiziana Comito
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.

Authors:  Marta Scorsetti; Elena Clerici; Piera Navarria; Giuseppe D'Agostino; Lorenzo Piergallini; Fiorenza De Rose; Annamaria Ascolese; Angelo Tozzi; Cristina Iftode; Elisa Villa; Tiziana Comito; Ciro Franzese; Pietro Mancosu; Stefano Tomatis; Luca Cozzi
Journal:  Br J Radiol       Date:  2015-07-17       Impact factor: 3.039

4.  Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response.

Authors:  Rosario Mazzola; Alba Fiorentino; Francesco Ricchetti; Niccolò Giaj Levra; Sergio Fersino; Gioacchino Di Paola; Antonio Lo Casto; Ruggero Ruggieri; Filippo Alongi
Journal:  Br J Radiol       Date:  2016-06-01       Impact factor: 3.039

Review 5.  Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Authors:  Sarah A Mattonen; Aaron D Ward; David A Palma
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

6.  Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer.

Authors:  M I Martínez-Fernández; J L Pérez Gracia; I Gil-Bazo; R Martínez-Monge
Journal:  Clin Transl Oncol       Date:  2015-10-19       Impact factor: 3.405

Review 7.  Radical irradiation of extracranial oligometastases.

Authors:  Joseph K Salama; Michael T Milano
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

8.  Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer.

Authors:  B Detti; P Bonomo; L Masi; R Doro; S Cipressi; C Iermano; I Bonucci; D Franceschini; L Di Brina; M Bakhi; G Simontacchi; I Meattini; L Livi
Journal:  World J Urol       Date:  2014-10-24       Impact factor: 4.226

Review 9.  Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.

Authors:  Young Seok Seo; Mi-Sook Kim; Hyung-Jun Yoo; Won-Il Jang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

10.  Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study.

Authors:  Rosario Mazzola; Sergio Fersino; Giuseppe Ferrera; Giovanni Targher; Vanessa Figlia; Luca Triggiani; Nadia Pasinetti; Antonio Lo Casto; Ruggero Ruggieri; Stefano Maria Magrini; Filippo Alongi
Journal:  Med Oncol       Date:  2018-08-04       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.